Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,721,889 papers from all fields of science
Search
Sign In
Create Free Account
A-56268
Known as:
A 56268
, A56268
, Abbott-56268
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Clarithromycin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Individual efficacy of clarithromycin (A-56268) and its major human metabolite 14-hydroxy clarithromycin (A-62671) in experimental pneumococcal pneumonia in the mouse.
J. Bédos
,
E. Azoulay-Dupuis
,
E. Vallée
,
B. Veber
,
J. Pocidalo
Journal of Antimicrobial Chemotherapy
1992
Corpus ID: 29000903
In man, clarithromycin (A-56268) is metabolized to a 14-hydroxy derivative (14-OH clarithromycin, A-62671); this metabolite is…
Expand
1989
1989
[Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis].
H. Takeda
,
H. Miura
,
M. Kawahira
,
H. Kobayashi
,
S. Otomo
,
S. Nakaike
Kansenshogaku zasshi. The Journal of the Japanese…
1989
Corpus ID: 46006260
TE-031 (A-56268), a new macrolide antibiotics, was administered on a long-term basis (6 months) to 12 patients with diffuse…
Expand
Highly Cited
1989
Highly Cited
1989
Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
D. M. Liebers
,
A. Baltch
,
Raymond P. Smith
,
M. Hammer
,
Joseph V. Conroy
Journal of Antimicrobial Chemotherapy
1989
Corpus ID: 36572225
A comparison of agar dilution and microdilution susceptibility testing for eight antimicrobial agents, including roxithromycin…
Expand
1989
1989
A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
S. Kohno
,
H. Koga
,
+7 authors
A. Saito
Journal of Antimicrobial Chemotherapy
1989
Corpus ID: 21071552
The activity of a new macrolide, TE-031 (A-56268), against Legionella pneumophila in vitro was superior to the activities of…
Expand
Highly Cited
1988
Highly Cited
1988
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin
A. Barry
,
Ronald N. Jones
,
C. Thornsberry
Antimicrobial Agents and Chemotherapy
1988
Corpus ID: 39606257
The in vitro activity of azithromycin (CP 62,993 or XZ-450) against Haemophilus influenzae was greater than that of three other…
Expand
1988
1988
Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
Hernan R. Chang
,
Florin C. Rudareanu
,
J. Pechère
Journal of Antimicrobial Chemotherapy
1988
Corpus ID: 29869492
The activity of A-56268 (TE-031), a new macrolide, was tested in a murine model of acute toxoplasmosis. All control animals died…
Expand
1988
1988
Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
D. M. Liebers
,
A. Baltch
,
R. Smith
,
M. Hammer
,
J. Conroy
,
M. Shayegani
Journal of Antimicrobial Chemotherapy
1988
Corpus ID: 21396919
The inhibitory (MIC) and bactericidal (MBC) activities of a new macrolide A-56268 (TE-031) against 306 clinical aerobic bacterial…
Expand
1987
1987
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms
C. Benson
,
J. Segreti
,
+4 authors
G. Trenholme
Antimicrobial Agents and Chemotherapy
1987
Corpus ID: 39528103
The in vitro activity of A-56268 was determined and compared with that of erythromycin and clindamycin against a limited spectrum…
Expand
1987
1987
Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
G. Eliopoulos
,
E. Reiszner
,
M. Ferraro
,
R. Moellering
Journal of Antimicrobial Chemotherapy
1987
Corpus ID: 21830113
The comparative in-vitro activity of A-56268 (TE-031), a new semisynthetic macrolide antibiotic, was assessed against…
Expand
1987
1987
Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031)
C. W. Hanson
,
R. Bailer
,
E. Gade
,
R. Rode
,
P. Fernandes
Journal of Clinical Microbiology
1987
Corpus ID: 19760525
A-56268 is a 6-O-methyl derivative of erythromycin A which has a spectrum of activity similar to that of erythromycin and is 1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE